Mounjaro After Gallbladder Removal: What You Need to Know

Does having no gallbladder stop you taking Mounjaro?

Not categorically. The Mounjaro SmPC (the prescribing document regulated by the MHRA) does not list cholecystectomy as a contraindication. What it does list are gallbladder-related conditions as known side effects of the medicine, including cholelithiasis (gallstone formation) and cholecystitis. If your gallbladder is already gone, those particular outcomes are off the table. That part is simpler.

The part that isn't simpler: tirzepatide slows how quickly the stomach empties and alters the pattern of bile acid release. When you have a gallbladder, bile is stored and released in a controlled surge after meals. Without one, bile drips continuously into the small intestine. Add a medicine that further changes gastric transit and you may get digestive symptoms that are harder to attribute, is that nausea from the medicine, or a different reaction to bile flow, or both? A prescriber who knows your surgical history can help you make sense of that distinction.

The full side-effect profile of Mounjaro is worth reading before you start, and if you want to go deeper before your consultation, you can find a detailed guide to taking Mounjaro after your gallbladder has been removed available to read through at your own pace.

What symptoms should you actually watch for after starting treatment?

The gastrointestinal side effects of tirzepatide (nausea, loose stools, bloating, indigestion) are common across everyone who takes it, peaking in the first days after a new dose and usually settling within a week or two. NHS guidance on tirzepatide covers these well and is worth bookmarking for reference.

For someone without a gallbladder, the pattern to watch is upper-right abdominal discomfort that persists beyond the usual early adjustment period, or that is distinctly different in character from ordinary nausea. If you are weighing up whether taking Mounjaro is appropriate when you've had your gallbladder removed, understanding these specific risks is a useful place to start. Bile duct issues (choledocholithiasis, for instance, where a stone remains in the duct after cholecystectomy) can occasionally produce symptoms that superficially resemble GI side effects of the medicine.

A practical habit worth forming: before each new dose, spend thirty seconds noting how your abdomen felt over the past week. Any right-sided or centre-upper pain that lingered, any yellowing of the skin or whites of the eyes, any pale stools or dark urine, write it down. These details help a prescriber distinguish medicine-related GI symptoms from something else entirely. That same list of observations is what you would give to a clinician or A&E if you needed urgent help.

More on an unusual reported symptom (swollen lymph nodes during Mounjaro treatment) is covered separately for anyone who has noticed that alongside GI changes.

When does abdominal pain become a medical emergency?

This is the section that matters most. The MHRA issued a Drug Safety Update in January 2026 specifically flagging acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines. The symptom to recognise is severe, persistent stomach pain that reaches through to your back, particularly when accompanied by vomiting. That combination warrants a 999 call or immediate attendance at A&E, not a text to your pharmacy and not waiting to see whether it settles.

Separately, any sudden onset of jaundice (yellowing skin or eyes), fever with rigors, or very pale stools alongside upper abdominal pain should be treated the same way. These point to potential bile duct obstruction or other hepatobiliary problems, which are independent of whether you still have a gallbladder. The absence of a gallbladder does not eliminate bile duct risk entirely.

If you experience a serious reaction or something you cannot explain, you can report it directly to the MHRA via the Yellow Card scheme, it genuinely helps improve safety monitoring for everyone on these medicines.

How does a prescriber actually assess this at consultation?

At nume, your consultation is read by a GPhC-registered Independent Prescriber (a named clinician, not an automated filter) who looks at your full health picture. A history of cholecystectomy prompts a more detailed review: why was the gallbladder removed, were there duct complications, do you have ongoing digestive symptoms now, are there other conditions in play?

The decision isn't binary. A prescriber might approve treatment with a specific note to monitor closely at the early titration stages. They might recommend beginning at the lowest dose and titrating more slowly. In a small number of cases, they might conclude the risk profile isn't right and suggest an alternative. That's what clinical assessment looks like in practice, and it's why the consultation exists.

You can read more about the broader Mounjaro treatment overview or explore other weight-loss treatment options if you want to understand the landscape before speaking to us. When you're ready, start your free consultation and our prescribers will discuss your specific situation, including your surgical history, as part of the process.